Two ZnII mononuclear coordination compounds with pyridinedicarboxylate and auxiliary N‐(pyridin‐4‐ylmethylidene)hydroxylamine ligands

Two new mononuclear coordination compounds, bis{4‐[(hydroxyimino)methyl]pyridinium} diaquabis(pyridine‐2,5‐dicarboxylato‐κ²N,O²)zincate(II), (C₆H₇N₂O)₂[Zn(C₇H₃NO₄)₂(H₂O)₂], (1), and (pyridine‐2,6‐dicarboxylato‐κ³O²,N,O⁶)bis[N‐(pyridin‐4‐ylmethylidene‐κN)hydroxylamine]zinc(II), [Zn(C₇H₃NO₄)(C₆H₆N₂O)₂], (2), have been synthesized and characterized by single‐crystal X‐ray diffractometry. The centrosymmetric Zn^II cation in (1) is octahedrally coordinated by two chelating pyridine‐2,5‐dicarboxylate ligands and by two water molecules in a distorted octahedral geometry. In (2), the Zn^II cation is coordinated by a tridentate pyridine‐2,6‐dicarboxylate dianion and by two N‐(pyridin‐4‐ylmethylidene)hydroxylamine molecules in a distorted C₂‐symmetric trigonal bipyramidal coordination geometry.     

Supramolecular hydrogen‐bonding patterns in two cocrystals of the N(7)–H tautomeric form of N6‐benzoyladenine: N6‐benzoyladenine–3‐hydroxypyridinium‐2‐carboxylate (1/1) and N6‐benzoyladenine–DL‐tartaric acid (1/1)

Two novel cocrystals of the N(7)—H tautomeric form of N⁶‐benzoyladenine (BA), namely N⁶‐benzoyladenine–3‐hydroxypyridinium‐2‐carboxylate (3HPA) (1/1), C₁₂H₉N₅O·C₆H₅NO₃, (I), and N⁶‐benzoyladenine–DL‐tartaric acid (TA) (1/1), C₁₂H₉N₅O·C₄H₆O₆, (II), are reported. In both cocrystals, the N⁶‐benzoyladenine molecule exists as the N(7)—H tautomer, and this tautomeric form is stabilized by intramolecular N—H...O hydrogen bonding between the benzoyl C=O group and the N(7)—H hydrogen on the Hoogsteen site of the purine ring, forming an S(7) motif. The dihedral angle between the adenine and phenyl planes is 0.94 (8)° in (I) and 9.77 (8)° in (II). In (I), the Watson–Crick face of BA (N6—H and N1; purine numbering) interacts with the carboxylate and phenol groups of 3HPA through N—H...O and O—H...N hydrogen bonds, generating a ring‐motif heterosynthon [graph set R₂²(6)]. However, in (II), the Hoogsteen face of BA (benzoyl O atom and N7; purine numbering) interacts with TA (hydroxy and carbonyl O atoms) through N—H...O and O—H...O hydrogen bonds, generating a different heterosynthon [graph set R₂²(4)]. Both crystal structures are further stabilized by π–π stacking interactions.     

Synthesis and Crystal Structure of a New Oxovanadium（V） Multicomponent Complex with Acylhydrazone and Benzoylhydrazine

A new oxovanadium（V） complex with the mixed ligand of 2-oxopropionic acid benzoylhydrazone （C10H10N2O3） and benzoylhydrazine （C7H8N2O）, VO（C7H7N2O）（C10H9N2O3）, has been synthesized. Its structure was determined by single crystal X-ray diffraction analysis. The crystal belongs to monoclinic system with space group P21/n and cell parameters： a=1.1136（4） nm, b=0.6217（2） nm, c=2.6038（9） nm, β=97.182（6）°, V= 1.7887（11） nm^3, Z=4, F（000）=836, Mr=407.28, Dc= 1.512 g/cm^3,μ （Mo Kα） =0.592 mm^-1, R1 =0.0445, wR2= 0.1203. Vanadium atom is 6-coordinated by carboxyl and carbonyl O atoms and N atom of one tridentate C10H10N2O3 to form two stable five-membered rings with the same edge, and the other coordinated atoms of N and O come from one bidentate benzoylhydrazine C7H8N2O. The title complex has a six-coordinated V center [VO（N2O3）] with a distorted octahedral arrangement. In the crystal lattice, there are hydrogen bonding interactions between two molecules.     

Three complexes of bis(N‐methyl­benzo­hydro­xamato‐O,O′)copper(II)

The first single‐crystal studies of three bis‐transoid Cu–hydrox­amate salts, bis(3‐methoxy‐4,N‐dimethyl­benzo­hydrox­amato‐O,O′)copper(II), [Cu(C₁₀H₁₂NO₃)₂], bis(4‐chloro‐N‐methyl­benzo­hydro­xamato‐O,O′)copper(II), [Cu­(C₈­H₇­Cl­NO₂)₂], bis(N‐methyl‐3,5‐di­nitro­benzo­hydro­xamato‐O,O′)copper(II)–chloro­form (1/2), [Cu­(C₈­H₆­N₃O₆)₂]·­2CHCl₃, are presented. The Cu atom in each of the title compounds sits at a center of inversion and displays a nearly square‐planar geometry with the hydro­xamate‐O atoms connected to it in a syn configuration. The N atoms are in a transoid configuration. Each five‐membered Cu–hydro­xamate ring is planar, thus providing evidence that a planar N atom is present in each ring. The phenyl groups are twisted with respect to the hydro­xamate group by ～40–54°. The angular strain of the sp² carbonyl oxy­gen is significant (～10° from ideal).     

catena‐Poly[copper(II)‐di‐μ‐acetylacetonato‐copper(II)‐bis(μ‐4‐hydroxy‐3‐methoxybenzaldehyde picoloylhydrazonato)] and (acetylacetonato)(4‐methoxybenzaldehyde picoloylhydrazonato)copper(II)

In the two title copper(II) complexes, [CuL(C₅H₇O₂)]_n, (I), and [CuL′(C₅H₇O₂)], (II), respectively, where HL is 4‐hydroxy‐3‐methoxybenzaldehyde picoloylhydrazone, C₁₄H₁₂N₃O₃, and HL′ is 4‐methoxybenzaldehyde picoloylhydrazone, C₁₄H₁₂N₃O₂, the Cu^II ions display a highly Jahn–Teller‐distorted octahedral and a square‐planar coordination geometry, respectively. In complex (I), two neighbouring Cu^II atoms are bridged by L⁻ and acetylacetonate, alternately, giving rise to a one‐dimensional chain of CuN₂O₄ octahedra interconnected by these two ligands along the a axis. In addition, the hydroxy H atom of the vanillin group connects to the carboxyl O atom of the adjacent chain via an O—H...O hydrogen bond, giving rise to a three‐dimensional supramolecular assembly. Complex (II) displays a discrete structure.     

Synthesis of Thiocyameluric Acid C6N7S3H3, Its Reaction to Alkali Metal Thiocyamelurates and Organic Tris(dithio)cyamelurates

Thiocyameluric acid C₆N₇S₃H₃, the tri-thio analogue of cyameluric acid, is a key compound for the synthesis of new s-heptazine (tri-s-triazine) derivatives. Here, two different routes for the synthesis of thiocyameluric acid and its reaction to tris(aryldithio)- and tris(alkyldithio)cyamelurates C₆N₇(SSR)₃ are reported as well as transformation to alkali metal thiocyamelurates M₃[C₆N₇S₃], M=Na, K. These compounds were characterised by FTIR, Raman, solution ¹³C and ¹H NMR spectroscopies, thermal gravimetric analysis (TGA) and elemental analysis. The three (de)protonation steps of thiocyameluric acid were investigated by acid–base titration followed via UV/Vis absorption spectroscopy. While it was not possible to determine the three pK_a values, it could be postulated that the acid strength probably increases in the following order: cyanuric acid (C₃N₃O₃H₃) < thiocyanuric acid (C₃N₃S₃H₃) < cyameluric acid (C₆N₇O₃H₃) < thiocyameluric acid (C₆N₇S₃H₃). Single crystals of Na₃[C₆N₇S₃]⋅10 H₂O and K₃[C₆N₇S₃]⋅6 H₂O were obtained and the structures analyzed by single crystal X-ray diffraction. Additionally, quantum chemical calculations were performed to get insights into the electronic structure of thiocyameluric acid and to clarify the thiol–thione tautomerism. Based on a comparison of calculated and measured vibrational spectra it can be concluded that thiocyameluric acid and the di- and mono-protonated anions exist in the thione form.     

trans‐Bis­[1‐methyl‐3‐(p‐nitro­phenyl)­triazenido 1‐oxide‐κ2N3,O]­di­pyridine­nickel(II)

In the centrosymmetric title complex, [Ni(C₇H₇N₄O₃)₂(C₅H₅N)₂], the coordination geometry about the Ni²⁺ ion is octahedral, with two deprotonated 1‐methyl‐3‐(p‐nitro­phenyl)­triazenide 1‐oxide ions, viz. [O₂N­C₆H₄­NNN(O)­CH₃]^?, acting as bidentate ligands (four‐electron donors). Two neutral pyridine (py) mol­ecules complete the coordination sphere in positions trans to each other. The triazenide 1‐oxide ligand is almost planar, the largest interplanar angle of 8.80 (12)° being between the phenyl ring of the p‐nitro­phenyl group and the plane defined by the N₃O moiety. The Ni—N_triazenide, Ni—O and Ni—N_py distances are 2.0794 (16), 2.0427 (13) and 2.1652 (18) Å, respectively.     

Purine 3′:5′‐cyclic nucleotides with the nucleobase in a syn orientation: cAMP,cGMP and cIMP

Purine 3′:5′‐cyclic nucleotides are very well known for their role as the secondary messengers in hormone action and cellular signal transduction. Nonetheless, their solid‐state conformational details still require investigation. Five crystals containing purine 3′:5′‐cyclic nucleotides have been obtained and structurally characterized, namely adenosine 3′:5′‐cyclic phosphate dihydrate, C₁₀H₁₂N₅O₆P·2H₂O or cAMP·2H₂O, (I), adenosine 3′:5′‐cyclic phosphate 0.3‐hydrate, C₁₀H₁₂N₅O₆P·0.3H₂O or cAMP·0.3H₂O, (II), guanosine 3′:5′‐cyclic phosphate pentahydrate, C₁₀H₁₂N₅O₇P·5H₂O or cGMP·5H₂O, (III), sodium guanosine 3′:5′‐cyclic phosphate tetrahydrate, Na⁺·C₁₀H₁₁N₅O₇P⁻·4H₂O or Na(cGMP)·4H₂O, (IV), and sodium inosine 3′:5′‐cyclic phosphate tetrahydrate, Na⁺·C₁₀H₁₀N₄O₇P⁻·4H₂O or Na(cIMP)·4H₂O, (V). Most of the cyclic nucleotide zwitterions/anions [two from four cAMP present in total in (I) and (II), cGMP in (III), cGMP⁻ in (IV) and cIMP⁻ in (V)] are syn conformers about the N‐glycosidic bond, and this nucleobase arrangement is accompanied by C_rib—H…N_pur hydrogen bonds (rib = ribose and pur = purine). The base orientation is tuned by the ribose pucker. An analysis of data obtained from the Cambridge Structural Database made in the context of syn–anti conformational preferences has revealed that among the syn conformers of various purine nucleotides, cyclic nucleotides and dinucleotides predominate significantly. The interactions stabilizing the syn conformation have been indicated. The inter‐nucleotide contacts in (I)–(V) have been systematized in terms of the chemical groups involved. All five structures display three‐dimensional hydrogen‐bonded networks.     

Eight new crystal structures of 5‐(hydroxymethyl)uracil, 5‐carboxyuracil and 5‐carboxy‐2‐thiouracil: insights into the hydrogen‐bonded networks and the predominant conformations of the C5‐bound residues

In order to examine the preferred hydrogen‐bonding pattern of various uracil derivatives, namely 5‐(hydroxymethyl)uracil, 5‐carboxyuracil and 5‐carboxy‐2‐thiouracil, and for a conformational study, crystallization experiments yielded eight different structures: 5‐(hydroxymethyl)uracil, C₅H₆N₂O₃, (I), 5‐carboxyuracil–N,N‐dimethylformamide (1/1), C₅H₄N₂O₄·C₃H₇NO, (II), 5‐carboxyuracil–dimethyl sulfoxide (1/1), C₅H₄N₂O₄·C₂H₆OS, (III), 5‐carboxyuracil–N,N‐dimethylacetamide (1/1), C₅H₄N₂O₄·C₄H₉NO, (IV), 5‐carboxy‐2‐thiouracil–N,N‐dimethylformamide (1/1), C₅H₄N₂O₃S·C₃H₇NO, (V), 5‐carboxy‐2‐thiouracil–dimethyl sulfoxide (1/1), C₅H₄N₂O₃S·C₂H₆OS, (VI), 5‐carboxy‐2‐thiouracil–1,4‐dioxane (2/3), 2C₅H₄N₂O₃S·3C₆H₁₂O₃, (VII), and 5‐carboxy‐2‐thiouracil, C₁₀H₈N₄O₆S₂, (VIII). While the six solvated structures, i.e. (II)–(VII), contain intramolecular S(6) O—H…O hydrogen‐bond motifs between the carboxy and carbonyl groups, the usually favoured R₂²(8) pattern between two carboxy groups is formed in the solvent‐free structure, i.e. (VIII). Further R₂²(8) hydrogen‐bond motifs involving either two N—H…O or two N—H…S hydrogen bonds were observed in three crystal structures, namely (I), (IV) and (VIII). In all eight structures, the residue at the ring 5‐position shows a coplanar arrangement with respect to the pyrimidine ring which is in agreement with a search of the Cambridge Structural Database for six‐membered cyclic compounds containing a carboxy group. The search confirmed that coplanarity between the carboxy group and the cyclic residue is strongly favoured.     

(2,2′‐Bi­pyridine‐κ2N,N′)(2,3‐naph­tha­lene­diolato‐κ2O,O′)­palladium(II) and (2,2′‐bi­quinoline‐κ2N,N′)(2,3‐naph­thal­ene­diolato‐κ2O,O′)­palladium(II)

In the title compounds, [Pd(C₁₀H₆O₂)(C₁₀H₈N₂)], (I), and [Pd(C₁₀H₆O₂)(C₁₈H₁₂N₂)], (II), each Pd^II atom has a similar distorted cis‐planar four‐coordination geometry involving two O atoms of the 2,3‐­naphthalenediolate dianion and two N atoms of the 2,2′‐bi­pyridine or 2,2′‐bi­quinoline ligand. The overall structure of (I) is essentially planar, but that of (II) is not, as a result of intramolecular overcrowding leading to bowing of the bi­quinoline ligand.     

Heteropolymolybdate–amino acid complexes: synthesis,characterization and biological activity

Three Keggin-type polyoxometalates functionalized by amino acids, (C₅H₁₃N₂O₂)₂(H₃O)PMo₁₂O₄₀·8H₂O 1, (C₅H₁₄N₂O₂)₂SiMo₁₂O₄₀·12H₂O 2 and (C₅H₁₄N₂O₂)₂GeMo₁₂O₄₀·12H₂O 3, were synthesized and characterized by elemental analysis, IR and ¹H?NMR spectra and single-crystal X-ray diffraction. The X-ray crystallographic study showed that the structures of the three compounds involved N–H···O and O–H···O hydrogen bonds among the protonated ornithine cations, water molecules and the heteropolyanion cluster, and thus represent a model interaction between polyoxometalates and proteins. These complexes display inhibitory actions to the human cancer cells Hela and PC-3?m in vitro.     

Structures of CoII and ZnII complexes of the proton‐transfer compound derived from pyrazine‐2,3‐dicarboxylic acid and piperazine

The reaction of the proton‐transfer compound piperazine‐1,4‐diium pyrazine‐2,3‐dicarboxylate 4.5‐hydrate, C₄H₁₂N₂²⁺·C₆H₂N₂O₄²⁻·4.5H₂O or (pipzH₂)(pyzdc)·4.5H₂O (pyzdcH₂ is pyrazine‐2,3‐dicarboxylic acid and pipz is piperazine), (I), with Zn(NO₃)₂·6H₂O and CoCl₂·6H₂O results in the formation of bis(piperazine‐1,4‐diium) bis(μ‐pyrazine‐2,3‐dicarboxylato)‐κ³N¹,O²:O³;κ³O³:N¹,O²‐bis[aqua(pyrazine‐2,3‐dicarboxylato‐κ²N¹,O²)zinc(II)] decahydrate, (C₄H₁₂N₂)₂[Zn₂(C₆H₂N₂O₄)₄(H₂O)₂]·10H₂O or (pipzH₂)₂[Zn(pyzdc)₂(H₂O)]₂·10H₂O, (II), and catena‐poly[piperazine‐1,4‐diium [cobalt(II)‐bis(μ‐pyrazine‐2,3‐dicarboxylato)‐κ³N¹,O²:O³;κ³O³:N¹,O²] hexahydrate], {(C₄H₁₂N₂)[Co(C₆H₂N₂O₄)₂]·6H₂O}_n or {(pipzH₂)[Co(pyzdc)₂]·6H₂O}_n, (III), respectively. In (I), pyzdcH₂ is doubly deprotonated on reaction with piperazine as a base. Compound (II) crystallizes as a dimer, whereas compound (III) exists as a one‐dimensional coordination polymer. In (II), two pyzdc²⁻ groups chelate to each of the two Zn^II atoms through a ring N atom and an O atom of the 2‐carboxylate group. In one ligand, the adjacent 3‐carboxylate group bridges to a neighbouring metal atom. A water molecule ligates in the sixth coordination site. The structure of (II) can be described as a commensurate superlattice due to an ordering in the hydrogen‐bonded network. In (III), no water is coordinated to the metal atom and the coordination sphere is comprised of two N,O‐chelates plus two bridging O atoms. A large number of hydrogen bonds are observed in all three compounds. These interactions, as well as π–π and C=O...π stacking interactions, play important structural roles.     

A ferric-cyanide-bridged one-dimensional dirhodium complex with (18-­crown-6)­potassium cations

The crystal structure of the title compound, catena-poly[bis[aqua(18-crown-6)­potassium] di­aqua(18-crown-6)­potassium [[tetra-μ-benzoato-2:3κ⁸O:O′-μ-cyano-1:2κ²C:N-tetra­cyano-1κC-irondirhodium(Rh—Rh)]-μ-cyano-1κC:3′κN] octahydrate], [K(18-crown-6)(H₂O)]₂[K(18-crown-6)(H₂O)₂]­[FeRh₂(C₇H₅O₂)₄(CN)₆]·8H₂O, where (18-crown-6) is 1,4,7,10,13,16-hexaoxa­cyclo­octa­decane (C₁₂H₂₄O₆), has been determined. Ferric cyanides connect the dirhodium units to form a one-dimensional chain compound. [K(18-crown-6-ether)(H₂O)₂] cations (with inversion symmetry) and [K(18-crown-6-ether)(H₂O)] cations (in general positions) are located between the chains.     

Three novel topologically different metal–organic frameworks built from 3‐nitro‐4‐(pyridin‐4‐yl)benzoic acid

The design and synthesis of metal–organic frameworks (MOFs) have attracted much interest due to the intriguing diversity of their architectures and topologies. However, building MOFs with different topological structures from the same ligand is still a challenge. Using 3‐nitro‐4‐(pyridin‐4‐yl)benzoic acid (HL) as a new ligand, three novel MOFs, namely poly[[(N,N‐dimethylformamide‐κO)bis[μ₂‐3‐nitro‐4‐(pyridin‐4‐yl)benzoato‐κ³O,O′:N]cadmium(II)] N,N‐dimethylformamide monosolvate methanol monosolvate], {[Cd(C₁₂H₇N₂O₄)₂(C₃H₇NO)]·C₃H₇NO·CH₃OH}_n, ( 1 ), poly[[(μ₂‐acetato‐κ²O:O′)[μ₃‐3‐nitro‐4‐(pyridin‐4‐yl)benzoato‐κ³O:O′:N]bis[μ₃‐3‐nitro‐4‐(pyridin‐4‐yl)benzoato‐κ⁴O,O′:O′:N]dicadmium(II)] N,N‐dimethylacetamide disolvate monohydrate], {[Cd₂(C₁₂H₇N₂O₄)₃(CH₃CO₂)]·2C₄H₉NO·H₂O}_n, ( 2 ), and catena‐poly[[[diaquanickel(II)]‐bis[μ₂‐3‐nitro‐4‐(pyridin‐4‐yl)benzoato‐κ²O:N]] N,N‐dimethylacetamide disolvate], {[Ni(C₁₂H₇N₂O₄)₂(H₂O)₂]·2C₄H₉NO}_n, ( 3 ), have been prepared. Single‐crystal structure analysis shows that the Cd^II atom in MOF ( 1 ) has a distorted pentagonal bipyramidal [CdN₂O₅] coordination geometry. The [CdN₂O₅] units as 4‐connected nodes are interconnected by L^? ligands to form a fourfold interpenetrating three‐dimensional (3D) framework with a dia topology. In MOF ( 2 ), there are two crystallographically different Cd^II ions showing a distorted pentagonal bipyramidal [CdNO₆] and a distorted octahedral [CdN₂O₄] coordination geometry, respectively. Two Cd^II ions are connected by three carboxylate groups to form a binuclear [Cd₂(COO)₃] cluster. Each binuclear cluster as a 6‐connected node is further linked by acetate groups and L^? ligands to produce a non‐interpenetrating 3D framework with a pcu topology. MOF ( 3 ) contains two crystallographically distinct Ni^II ions on special positions. Each Ni^II ion adopts an elongated octahedral [NiN₂O₄] geometry. Each Ni^II ion as a 4‐connected node is linked by L^? ligands to generate a two‐dimensional network with an sql topology, which is further stabilized by two types of intermolecular OW—HW…O hydrogen bonds to form a 3D supramolecular framework. MOFs ( 1 )–( 3 ) were also characterized by powder X‐ray diffraction, IR spectroscopy and thermogravimetic analysis. Furthermore, the solid‐state photoluminescence of HL and MOFs ( 1 ) and ( 2 ) have been investigated. The photoluminescence of MOFs ( 1 ) and ( 2 ) are enhanced and red‐shifted with respect to free HL. The gas adsorption investigation of MOF ( 2 ) indicates a good separation selectivity (71) of CO₂/N₂ at 273 K (i.e. the amount of CO₂ adsorption is 71 times higher than N₂ at the same pressure).     

Zero‐, one‐ and two‐dimensional hydrogen‐bonded structures in the 1:1 proton‐transfer compounds of 4,5‐dichlorophthalic acid with the monocyclic heteroaromatic Lewis bases 2‐aminopyrimidine,nicotinamide and isonicotinamide

The structures of the anhydrous 1:1 proton‐transfer compounds of 4,5‐dichlorophthalic acid (DCPA) with the monocyclic heteroaromatic Lewis bases 2‐aminopyrimidine, 3‐(aminocarbonyl)pyridine (nicotinamide) and 4‐(aminocarbonyl)pyridine (isonicotinamide), namely 2‐aminopyrimidinium 2‐carboxy‐4,5‐dichlorobenzoate, C₄H₆N₃⁺·C₈H₃Cl₂O₄⁻, (I), 3‐(aminocarbonyl)pyridinium 2‐carboxy‐4,5‐dichlorobenzoate, C₆H₇N₂O⁺·C₈H₃Cl₂O₄⁻, (II), and the unusual salt adduct 4‐(aminocarbonyl)pyridinium 2‐carboxy‐4,5‐dichlorobenzoate–methyl 2‐carboxy‐4,5‐dichlorobenzoate (1/1), C₆H₇N₂O⁺·C₈H₃Cl₂O₄⁻·C₉H₆Cl₂O₄, (III), have been determined at 130 K. Compound (I) forms discrete centrosymmetric hydrogen‐bonded cyclic bis(cation–anion) units having both R₂²(8) and R₁²(4) N—H...O interactions. In (II), the primary N—H...O‐linked cation–anion units are extended into a two‐dimensional sheet structure via amide–carboxyl and amide–carbonyl N—H...O interactions. The structure of (III) reveals the presence of an unusual and unexpected self‐synthesized methyl monoester of the acid as an adduct molecule, giving one‐dimensional hydrogen‐bonded chains. In all three structures, the hydrogen phthalate anions are essentially planar with short intramolecular carboxyl–carboxylate O—H...O hydrogen bonds [O...O = 2.393 (8)–2.410 (2) Å]. This work provides examples of low‐dimensional 1:1 hydrogen‐bonded DCPA structure types, and includes the first example of a discrete cyclic `heterotetramer.' This low dimensionality in the structures of the 1:1 aromatic Lewis base salts of the parent acid is generally associated with the planar DCPA anion species.     

Hydrogen bonding in C-methylated nitroanilines: three triclinic examples with Z′ = 2 or 4

4-Methyl-2-nitro­aniline, (I), C₇H₈N₂O₂, crystallizes with two mol­ecules in the asymmetric unit. The mol­ecules both form intramolecular N—H⃛O hydrogen bonds and they are linked into hydrogen-bonded C₂²(12) chains in which the two independent mol­ecules alternate. 4,5-Di­methyl-2-nitro­aniline, (II), C₈H₁₀N₂O₂, also has Z′ = 2 and the two independent mol­ecules each form hydrogen-bonded C(6) chains. In 4-­methyl-3-nitro­aniline, (III), C₇H₈N₂O₂, there are four mol­ecules in the asymmetric unit. Molecules of two of these types are linked by N—H⃛O hydrogen bonds into molecular ladders containing R₄³(18) rings and the other two types independently form single C(7) chains.     

One barbiturate and two solvated thiobarbiturates containing the triply hydrogen‐bonded ADA/DAD synthon,plus one ansolvate and three solvates of their coformer 2,4‐diaminopyrimidine

A path to new synthons for application in crystal engineering is the replacement of a strong hydrogen‐bond acceptor, like a C=O group, with a weaker acceptor, like a C=S group, in doubly or triply hydrogen‐bonded synthons. For instance, if the C=O group at the 2‐position of barbituric acid is changed into a C=S group, 2‐thiobarbituric acid is obtained. Each of the compounds comprises two ADA hydrogen‐bonding sites (D = donor and A = acceptor). We report the results of cocrystallization experiments of barbituric acid and 2‐thiobarbituric acid, respectively, with 2,4‐diaminopyrimidine, which contains a complementary DAD hydrogen‐bonding site and is therefore capable of forming an ADA/DAD synthon with barbituric acid and 2‐thiobarbituric acid. In addition, pure 2,4‐diaminopyrimidine was crystallized in order to study its preferred hydrogen‐bonding motifs. The experiments yielded one ansolvate of 2,4‐diaminopyrimidine (pyrimidine‐2,4‐diamine, DAPY), C₄H₆N₄, (I), three solvates of DAPY, namely 2,4‐diaminopyrimidine–1,4‐dioxane (2/1), 2C₄H₆N₄·C₄H₈O₂, (II), 2,4‐diaminopyrimidine–N,N‐dimethylacetamide (1/1), C₄H₆N₄·C₄H₉NO, (III), and 2,4‐diaminopyrimidine–1‐methylpyrrolidin‐2‐one (1/1), C₄H₆N₄·C₅H₉NO, (IV), one salt of barbituric acid, viz. 2,4‐diaminopyrimidinium barbiturate (barbiturate is 2,4,6‐trioxopyrimidin‐5‐ide), C₄H₇N₄⁺·C₄H₃N₂O₃⁻, (V), and two solvated salts of 2‐thiobarbituric acid, viz. 2,4‐diaminopyrimidinium 2‐thiobarbiturate–N,N‐dimethylformamide (1/2) (2‐thiobarbiturate is 4,6‐dioxo‐2‐sulfanylidenepyrimidin‐5‐ide), C₄H₇N₄⁺·C₄H₃N₂O₂S⁻·2C₃H₇NO, (VI), and 2,4‐diaminopyrimidinium 2‐thiobarbiturate–N,N‐dimethylacetamide (1/2), C₄H₇N₄⁺·C₄H₃N₂O₂S⁻·2C₄H₉NO, (VII). The ADA/DAD synthon was succesfully formed in the salt of barbituric acid, i.e. (V), as well as in the salts of 2‐thiobarbituric acid, i.e. (VI) and (VII). In the crystal structures of 2,4‐diaminopyrimidine, i.e. (I)–(IV), R₂²(8) N—H…N hydrogen‐bond motifs are preferred and, in two structures, additional R₃²(8) patterns were observed.     

Dimeric copper(II) 3,3‐dimethyl­butyrate adducts with ethanol, 2‐methylpyridine, 3‐methylpyridine, 4‐methylpyridine and 3,3‐dimethylbutyric acid

In the crystals of the five title compounds, tetrakis‐(μ‐3,3‐dimethylbutyrato‐O:O′)bis(ethanol‐O)dicopper(II)–ethanol (1/2), [Cu₂(C₆H₁₁O₂)₄(C₂H₆O)₂]·2C₂H₆O, (I), tetrakis(μ‐3,3‐dimethylbutyrato‐O:O′)bis(2‐methylpyridine‐N)di­copper(II), [Cu₂(C₆H₁₁O₂)₄(C₆H₇N)₂], (II), tetrakis‐(μ‐3,3‐dimethylbutyrato‐O:O′)bis(3‐methylpyridine‐N)di‐copper(II), [Cu₂(C₆H₁₁O₂)₄(C₆H₇N)₂], (III), tetrakis‐(μ‐3,3‐dimethylbutyrato‐O:O′)bis(4‐methylpyridine‐N)di‐copper(II), [Cu₂(C₆H₁₁O₂)₄(C₆H₇N)₂], (IV), and tetrakis‐(μ‐3,3‐dimethylbutyrato‐O:O′)bis(3,3‐dimethylbutyric acid‐O)dicopper(II), [Cu₂(C₆H₁₁O₂)₄(C₆H₁₂O₂)₂], (V), the di­nuclear Cu^II complexes all have centrosymmetric cage structures and (IV) has two independent molecules. The Cu?Cu separations are: (I) 2.602 (3) Å, (II) 2.666 (3) Å, (III) 2.640 (2) Å, (IV) 2.638 (4) Å and (V) 2.599 (1) Å.     

Two cobalt(III) mono‐dimethylglyoximates isolated from one reaction

The reaction of cobalt(II) nitrate hexahydrate with dimethylglyoxime (DMGH₂) and 1,10‐phenanthroline (phen) in a 1:1:2 molar ratio results in two Co^III mono‐dimethylglyoximates having two chelating phen ligands in cis positions and the Co^III atom coordinated by six N atoms in a distorted octahedral coordination geometry. The isolated products differ in the deprotonation state of the DMGH₂ ligand. In [μ‐hydrogen bis(N,N′‐dioxidobutane‐2,3‐diimine)]tetrakis(1,10‐phenanthroline)cobalt(III) trinitrate ethanol disolvate 1.87‐hydrate, [Co₂(C₄H₆N₂O₂)(C₄H₇N₂O₂)(C₁₂H₈N₂)₄](NO₃)₃·2C₂H₆O·1.87H₂O, (I), the C₂‐symmetric cation is formed with the coordination [Co(DMG)(phen)₂]⁺ cations aggregating via a very strong O⁻...H⁺...O⁻ hydrogen bond with an O...O distance of 2.409 (4) Å. Crystals of (I) exhibit extensive disorder of the solvent molecules, the nitrate anions and one of the phen ligands. Compound (I) is a kinetic product, not isolated previously from similar systems, that transforms slowly into (N‐hydroxy‐N′‐oxidobutane‐2,3‐diimine)bis(1,10‐phenanthroline)cobalt(III) dinitrate ethanol monosolvate 0.4‐hydrate, [Co(C₄H₇N₂O₂)(C₁₂H₈N₂)₂](NO₃)₂·C₂H₆O·0.40H₂O, (II), with the DMGH⁻ ligand hydrogen bonded to one of the nitrate anions. In (II), the solvent molecules and one of the nitrate anions are disordered.     

Six closely related 4,6‐disubstituted 2‐amino‐5‐formylpyrimidines: different ring conformations,polarized electronic structures,and hydrogen‐bonded assembly in zero,one, two and three dimensions

In each of ethyl N‐{2‐amino‐5‐formyl‐6‐[methyl(phenyl)amino]pyrimidin‐4‐yl}glycinate, C₁₆H₁₉N₅O₃, (I), N‐{2‐amino‐5‐formyl‐6‐[methyl(phenyl)amino]pyrimidin‐4‐yl}glycinamide, C₁₄H₁₆N₆O₂, (II), and ethyl 3‐amino‐N‐{2‐amino‐5‐formyl‐6‐[methyl(phenyl)amino]pyrimidin‐4‐yl}propionate, C₁₇H₂₁N₅O₃, (III), the pyrimidine ring is effectively planar, but in each of methyl N‐{2‐amino‐6‐[benzyl(methyl)amino]‐5‐formylpyrimidin‐4‐yl}glycinate, C₁₆H₁₉N₅O₃, (IV), ethyl 3‐amino‐N‐{2‐amino‐6‐[benzyl(methyl)amino]‐5‐formylpyrimidin‐4‐yl}propionate, C₁₈H₂₃N₅O₃, (V), and ethyl 3‐amino‐N‐[2‐amino‐5‐formyl‐6‐(piperidin‐4‐yl)pyrimidin‐4‐yl]propionate, C₁₅H₂₃N₅O₃, (VI), the pyrimidine ring is folded into a boat conformation. The bond lengths in each of (I)–(VI) provide evidence for significant polarization of the electronic structure. The molecules of (I) are linked by paired N—H...N hydrogen bonds to form isolated dimeric aggregates, and those of (III) are linked by a combination of N—H...N and N—H...O hydrogen bonds into a chain of edge‐fused rings. In the structure of (IV), molecules are linked into sheets by means of two hydrogen bonds, both of N—H...O type, in the structure of (V) by three hydrogen bonds, two of N—H...N type and one of C—H...O type, and in the structure of (VI) by four hydrogen bonds, all of N—H...O type. Molecules of (II) are linked into a three‐dimensional framework structure by a combination of three N—H...O hydrogen bonds and one C—H...O hydrogen bond.